Comments*

 
  • Microbiology, Immunology & Infectious Diseases

  • Events 

    Monday, September 15, 2014 | 12:00 PM - 4:00 PM

    Click Chemistry in Biology and Medicine: New Developments and Strategies

    Keynote Speakers: Jim Paulson (The Scripps Research Institute), K. Barry Sharpless (The Scripps Research Institute)
    Speakers: Yimon Aye (Cornell University), David A. Spiegel (Yale University), Peng Wu (Albert Einstein College of Medicine)

    Click chemistry offers a reliable method for discovering chemical connectivity, with great potential in drug discovery and biomedical research. This symposium explores recent developments that offer new technologies for disease diagnosis and therapy.

    Tuesday, September 30, 2014 | 8:30 AM - 5:00 PM

    Elucidating GPCR Functional Selectivity: Novel Opportunities for Drug Development

    Keynote Speaker: Nobel Laureate Robert J. Lefkowitz (Duke University Medical Center)
    Speakers: Bryan Roth (University of North Carolina at Chapel Hill School of Medicine), Terry Kenakin (University of North Carolina at Chapel Hill School of Medicine), Marc G. Caron (Duke University Medical Center), Laura Bohn (The Scripps Research Institute), Michael Ehlers (Pfizer), JoAnn Trejo (University of California-San Diego), Jonathan Violin (Trevena, Inc.)

    Hear academic, industry, basic and translational researchers, including Nobel Laureate Robert Lefkowitz (Duke University Medical Center) and discuss the development of functionally selective GPCR-biased ligands for CV and CNS disease drug discovery.

    Tuesday, October 28, 2014 | 8:30 AM - 5:00 PM

    Pharmacologic Resolution of Inflammation as a Novel Therapeutic Approach

    Speaker: Michael S. Conte (University of California-San Francisco, San Francisco, CA), Milan Fiala (David Geffen School of Medicine at UCLA, Los Angeles, CA), Gabrielle Fredman (Columbia University, New York, NY), Bruce Levy (Harvard University, Brigham and Women's Hospital, Boston, MA), Dipak Panigrahy (Beth Israel Deaconess Medical Center, Boston, MA), Mauro Perretti (William Harvey Research Institute, London, UK), Charles N. Serhan (Harvard University, New York, NY), Patricia J. Sime (University of Rochester School of Medicine, Rochester, NY), Rudy Tanzi (Massachusetts General Hospital, Charlestown, MA)

    Uncontrolled, chronic inflammation plays a key role in the progression of many diseases, and elucidation of biochemical pathways provides novel targets. This symposium reviews discoveries, approaches and opportunities for treatment and prevention.

  • Past Events

    Thursday, June 26, 2014 | 7:45 AM - 6:00 PM

    Demyelination and Remyelination: From Mechanism to Therapy

    Keynote Speaker: Robin Franklin (Wellcome Trust – MRC Cambridge Stem Cell Institute, University of Cambridge)

    This translational conference will highlight biological and clinical findings in myelin development, new techniques for brain imaging and for screening molecular targets, and novel therapeutics that promote remyelination.

    Monday, June 9, 2014 | 10:00 AM - 3:15 PM

    2014 Ross Prize in Molecular Medicine: Advances in Immunomodulation

    Featured Speakers: John J. O'Shea (National Institute of Arthritis and Musculoskeletal and Skin Diseases, NIH), James P. Allison (The University of Texas MD Anderson Cancer Center), Louis M. Staudt (National Cancer Institute, National Institutes of Health), Charles A. Dinarello (University of Colorado at Denver)

    This symposium will honor Dr. John O'Shea, the recipient of the 2014 Ross Prize in Molecular Medicine, in recognition of his discoveries in immunology and cytokine biology.

    Tuesday, May 20, 2014 | 8:30 AM - 5:00 PM

    Hot Technologies for Developing Next-Gen Biologics

    Speakers: Timothy Charlebois (Pfizer), David King (AnaptysBio Inc.), William M. Pardridge (Brain Research Institute, UCLA), Steven J. Projan (MedImmune), Sachdev Siddhu (University of Toronto), E. Sally Ward (UT Southwestern), Patrick C. Wilson (The University of Chicago), K. Dane Wittrup (Massachusetts Institute of Technology)

    New technologies are pivotal in developing next-generation biologics. This symposium highlights novel technologies in the discovery of new biologics, elucidating in vivo mechanisms of therapeutic proteins, and manufacturing and delivery processes.

    Monday, May 5, 2014 | 7:30 AM - 3:00 PM

    HIV 2014: Science, Community and Policy for Key Vulnerable Populations

    Speakers: Fareed Abdullah (South African National AIDS Council, Pretoria, South Africa), Frederick Altice (Yale School of Medicine, New Haven, CT, USA), Joe Amon (Human Rights Watch, New York, NY, USA), Chasity Andrews (Aaron Diamond AIDS Research Center, New York, NY, USA), Chris Beyrer (Johns Hopkins Bloomberg School of Public Health, Baltimore, PA, USA), Frances Cowan (Centre for Sexual Health and HIV/AIDS Research Zimbabwe, Zimbabwe), Anna-Louise Crago (University of Toronto, Canada), Steven Deeks (University of California - San Francisco, CA, USA), Jerome Kim (Walter Reed Army Institute of Research, Bethesda, MD, USA), Luiz Loures (UNAIDS, Geneva, Switzerland), Kristen Marks (Weill Cornell Medical College, New York, NY, USA), Daniel Raymond (Harm Reduction Coalition, New York, NY, USA), Pavlo Smyrnov (International HIV/AIDS Alliance in Ukraine, Ukraine)

    The UNAIDS' vision of zero new HIV infections, zero AIDS-related deaths and zero discrimination provides a clear path for HIV research and policy. This symposium convenes clinicians, scientists, activists and policy-makers with the shared goal of improving outcomes for HIV in key vulnerable populations.

  • Publications 

    eBriefing

    HIV 2014: Science, Community, and Policy for Key Vulnerable Populations

    Organizers: Chris Beyrer (Johns Hopkins Bloomberg School of Public Health), Peter Godfrey-Faussett (UNAIDS), Ani Shakarishvili (UNAIDS), Yegor Voronin (Global HIV Vaccine Enterprise), and Jennifer Henry (The New York Academy of Sciences)

    The UNAIDS vision of zero new HIV infections, zero AIDS-related deaths, and zero discrimination calls for a global approach to HIV research and policy. This eBriefing focuses on improving outcomes for HIV in key vulnerable populations.

    eBriefing

    Malaria 2014: Advances in Pathophysiology, Biology, and Drug Development

    Organizers: Johanna P. Daily (Albert Einstein College of Medicine), David A. Fidock (Columbia University Medical Center), and Jennifer Henry (The New York Academy of Sciences)
    Keynote Speakers: Jane M. Carlton (New York University), Rick M. Fairhurst (National Institute of Allergy and Infectious Diseases, NIH), and Terrie E. Taylor (Michigan State University)

    This eBriefing highlights a symposium held on World Malaria Day to examine breakthroughs in pathophysiology, drug development, and pre-erythrocytic and liver-stage biology.

    Annals

    The Year in Immunology

    Edited by Noel R. Rose (Johns Hopkins University, Baltimore, Maryland)

    This sixth installment of The Year in Immunology series focuses on myeloid cells and inflammation.

    Volume 1319

    Annals

    Steroids in Neuroendocrine Immunology and Therapy of Rheumatic Diseases II

    Edited by Maurizio Cutolo (University of Genoa), Rainer H. Straub (University Hospital Regensburg), Alfonse T. Masi (University of Illinois College of Medicine), and Johannes W.J. Bijlsma (University Medical Center Utrecht)

    This Annals volumes explores the involvement of glucocorticoids in neuroendocrine immune mechanisms in rheumatic diseases.

    Volume 1318

  • Podcasts

    Podcast
    April 2, 2010

    More than a Yogurt Cup

    Delve into the world of prebiotic and probiotic science. We talk to three people in the field and learn why keeping the good microbes in our bodies happy means a lot for health.

    Download (14 MB, 00:21:21)
  • Webinar Archives

    Webinar Archive
    March 2, 2010

    Emerging Infectious Diseases in Response to Climate Change

    Climate and weather are important components of complex ecosystems, and with these changes, the dynamic balance between the living components of ecosystems is often disturbed. Experts in climate change, climate policy, emerging infectious diseases and public health discussed the relevant and pressing issues that we as a global community face as the planet's climate is altered.

  • Translational Medicine Initiative

    Macy FoundationThe Translational Medicine Initiative represents a three-year partnership between the New York Academy of Sciences and the Josiah Macy, Jr. Foundation to support the translation of basic science research into clinical applications.

    Learn more at www.nyas.org/TransMed.